Noninvasive Measurements Predict Liver Fibrosis Well in Hepatitis C Virus Patients After Direct-Acting Antiviral Therapy
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Noninvasive Measurements Predict Liver Fibrosis Well in Hepatitis C Virus Patients After Direct-Acting Antiviral Therapy
Authors
Keywords
-
Journal
DIGESTIVE DISEASES AND SCIENCES
Volume -, Issue -, Pages -
Publisher
Springer Science and Business Media LLC
Online
2019-10-26
DOI
10.1007/s10620-019-05886-y
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Rapid decline of noninvasive fibrosis index values in patients with hepatitis C receiving treatment with direct-acting antiviral agents
- (2019) Wei-Fan Hsu et al. BMC GASTROENTEROLOGY
- Magnitude and Kinetics of Decrease in Liver Stiffness After Antiviral Therapy in Patients With Chronic Hepatitis C: A Systematic Review and Meta-analysis
- (2018) Siddharth Singh et al. Clinical Gastroenterology and Hepatology
- Hepatocellular carcinoma risk assessment by the measurement of liver stiffness variations in HCV cirrhotics treated with direct acting antivirals
- (2018) Federico Ravaioli et al. DIGESTIVE AND LIVER DISEASE
- Histological assessment of the liver explant in transplanted hepatitis C virus patients achieving sustained virological response with direct-acting antiviral agents
- (2018) Juan Putra et al. HISTOPATHOLOGY
- Long-term liver stiffness assessment in hepatitis C virus patients undergoing antiviral therapy: Results from a 5-year cohort study
- (2018) Antonio Facciorusso et al. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY
- Improvement of liver stiffness measurement, acoustic radiation force impulse measurements, and noninvasive fibrosis markers after direct-acting antivirals for hepatitis C virus G4 recurrence post living donor liver transplantation: Egyptian cohort
- (2018) Shereen Abdel Alem et al. JOURNAL OF MEDICAL VIROLOGY
- Short-term histological evaluations after achieving a sustained virologic response to direct-acting antiviral treatment for chronic hepatitis C
- (2018) Masaru Enomoto et al. United European Gastroenterology Journal
- Fibrosis Staging Using Direct Serum Biomarkers is Influenced by Hepatitis Activity Grading in Hepatitis C Virus Infection
- (2018) Koji Fujita et al. Journal of Clinical Medicine
- Improvement in hepatitis C virus patients with advanced, compensated liver disease after sustained virological response to direct acting antivirals
- (2018) Edoardo G. Giannini et al. EUROPEAN JOURNAL OF CLINICAL INVESTIGATION
- Predictors of hepatocellular carcinoma occurrence after direct-acting antiviral therapy in patients with hepatitis C virus infection
- (2018) Takao Watanabe et al. HEPATOLOGY RESEARCH
- Long-term histological change in chronic hepatitis C patients who had received peginterferon plus ribavirin therapy with sustained virological response
- (2018) Chia-Ying Chu et al. JOURNAL OF THE FORMOSAN MEDICAL ASSOCIATION
- Regression of liver fibrosis over a 24-week period after completing direct-acting antiviral therapy in patients with chronic hepatitis C receiving care within the national hepatitis C elimination program in Georgia
- (2017) Ekaterine Dolmazashvili et al. EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY
- Impact of different sofosbuvir based treatment regimens on the biochemical profile of chronic hepatitis C genotype 4 patients
- (2017) Aisha Elsharkawy et al. Expert Review of Gastroenterology & Hepatology
- Regression of fibrosis and portal hypertension in HCV-associated cirrhosis and sustained virologic response after interferon-free antiviral therapy
- (2016) V. Knop et al. JOURNAL OF VIRAL HEPATITIS
- Direct antiviral agent treatment of chronic hepatitis C results in rapid regression of transient elastography and fibrosis markers fibrosis-4 score and aspartate aminotransferase-platelet ratio index
- (2016) Jacqueline A. Bachofner et al. LIVER INTERNATIONAL
- AST-platelet ratio index, Forns index and FIB-4 in the prediction of significant fibrosis and cirrhosis in patients with chronic hepatitis C
- (2016) Fatih GUZELBULUT et al. Turkish Journal of Gastroenterology
- Successful treatment with telaprevir-based regimens for chronic hepatitis C results in significant improvements to serum markers of liver fibrosis
- (2015) E. L. Haseltine et al. JOURNAL OF VIRAL HEPATITIS
- Reversal, maintenance or progression: What happens to the liver after a virologic cure of hepatitis C?
- (2014) Youngmin A. Lee et al. ANTIVIRAL RESEARCH
- Non-invasive diagnosis of liver steatosis using controlled attenuation parameter (CAP) and transient elastography
- (2012) Victor Lédinghen et al. LIVER INTERNATIONAL
- Histologic outcomes in hepatitis C-infected patients with varying degrees of virologic response to interferon-based treatments
- (2010) Paul J. Pockros et al. HEPATOLOGY
- Reliability of transient elastography for the diagnosis of advanced fibrosis in chronic hepatitis C
- (2008) U Arena et al. GUT
- Clinical, virologic, histologic, and biochemical outcomes after successful HCV therapy: A 5-year follow-up of 150 patients
- (2008) Sarah L. George et al. HEPATOLOGY
- Transient elastography is unreliable for detection of cirrhosis in patients with acute liver damage
- (2008) Ze-Zhou Song HEPATOLOGY
- Non-invasive evaluation of liver fibrosis using transient elastography
- (2008) Laurent Castera et al. JOURNAL OF HEPATOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started